RecruitingNCT06657430

A Study on the Preference of Risperidone Dosage Forms


Sponsor

Shanghai Mental Health Center

Enrollment

1,000 participants

Start Date

Sep 19, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This survey-based study explores which form of risperidone — a psychiatric medication — patients or their caregivers prefer: tablets, liquid, or long-acting injections. It aims to understand patient preferences to improve medication adherence. **You may be eligible if...** - You or your child has been diagnosed with schizophrenia, bipolar disorder, autism spectrum disorder, or intellectual disability - You are a patient or primary caregiver willing to voluntarily participate - You can read and understand Chinese **You may NOT be eligible if...** - You have difficulty reading or understanding Chinese - You decline to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06657430


Related Trials